Pasi I Nevalainen

Tampere University Hospital
Country flagFinland

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (17)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Background Screening for primary aldosteronism is based on measuring aldosterone-to-renin ratio. Non-suppressed renin may cause false negative screening results, and such patients may miss focused, potentially curable treatment. We investigated the association between renal cysts and non-suppressed plasma renin. Methods Altogether, 114 consecutive patients with confirmed primary aldosteronism undergoing adrenal vein sampling were prospectively recruited between October 7, 2020 and December 30, 2021. During the procedure, plasma samples for renin analyses were collected from the right and left renal veins and the inferior vena cava. Renal cysts were identified using contrast-enhanced computed tomography. Results Renal cysts were found in 58.2% of the 114 patients. Neither screening nor renal vein renin concentrations were significantly different in patients with and without cysts, or when the kidneys with and without cysts were evaluated. However, cysts were significantly more prevalent in the “high-normal renin” group (cut point 23.0 mU/L) than in the “low to low-normal renin” group (90.9%, n = 11 vs. 56.0%, n = 102, P = .027, respectively). All patients ≤50 years of age in the “high-normal renin” group had renal cysts. Strong correlations were found between renin concentrations in the right and left renal veins (r = .984), and between renin concentration and renin activity in the inferior vena cava (r = .817). Conclusion Renal cysts are found in the majority of patients with primary aldosteronism, and they may interfere with diagnostics, especially in patients aged 50 years or less. In patients with non-suppressed renin due to renal cysts, aldosterone-to-renin ratio below the diagnostic threshold does not always exclude the diagnosis of primary aldosteronism.

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (22)

Eeva Kokko

University of Tampere

FINLAND
View details

Ilkka Pörsti

University of Tampere

FINLAND
View details

Mari Hämäläinen

University of Tampere

FINLAND
View details

Taina Viheriälä

Tampere University

FINLAND
View details

Manoj Kumar Choudhary

Tampere University Hospital

FINLAND
View details

Ina Knerr

Consultant Metabolic Paediatrician, Clinical Professor

-

IRELAND
View details

Pia Jaatinen

University of Tampere

FINLAND
View details

Reeta Rintamäki

Kuopio University Hospital

FINLAND
View details

Hannu Uusitalo

-

FINLAND
View details

Heli Skottman

Professor

University of Tampere

FINLAND
View details

Suvi Väärämäki

Tampere University Hospital

FINLAND
View details

Mikkel Andreassen

-

DENMARK
View details

Camilla Schalin-Jäntti

University of Helsinki

FINLAND
View details

Jens Otto Lunde Jørgensen

Aarhus University Hospital

DENMARK
View details

Niina Matikainen

-

FINLAND
View details

Tiina Vesterinen

University of Helsinki

FINLAND
View details

Jukka Kemppainen

Professor in Clinical Physiology and Nuclear Medicine

University of Turku

FINLAND
View details

Marjatta Sinisalo

University of Tampere

FINLAND
View details

Marianne S. Andersen

-

DENMARK
View details

Gwendolyn Gramer

-

GERMANY
View details

Ansgar Heck

Oslo University Hospital

NORWAY
View details

Eeva Moilanen

Professor of Pharmacology

-

FINLAND
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.